Glucose metabolism continuous deteriorating in male patients with human immunodeficiency virus accepted antiretroviral therapy for 156 weeks

BACKGROUND: The dynamic characteristics of glucose metabolism and its risk factors in patients living with human immunodeficiency virus (PLWH) who accepted primary treatment with the efavirenz (EFV) plus lamivudine (3TC) plus tenofovir (TDF) (EFV + 3TC + TDF) regimen are unclear and warrant investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Da-Feng, Zhang, Xin-Yi, Zhou, Rui-Feng, Cai, Lin, Yan, Dong-Mei, Lan, Li-Juan, He, Sheng-Hua, Tang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075030/
https://www.ncbi.nlm.nih.gov/pubmed/37035225
http://dx.doi.org/10.4239/wjd.v14.i3.299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075030/
https://www.ncbi.nlm.nih.gov/pubmed/37035225
http://dx.doi.org/10.4239/wjd.v14.i3.299

Ejemplares similares